Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
5
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
microbiome
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
5
×
texas blog main
texas top stories
wisconsin blog main
5
×
wisconsin top stories
clinical trials
novartis
pfizer
abbvie
amgen
astrazeneca
bristol-myers squibb
cancer
eli lilly
fda
merck
purdue pharma
What
bio
roundup
drug
fda
moves
news
week
acquisitions
advantages
america
approved
august
bar
biggest
biogen
biotech
brings
build
busy
buy
ceo
companies
company’s
continues
convoluted
daniel
days
debut
decisions
democrats
devices
digital
disease
dreams
drugs
dyne’s
epidemic
expect
fatty
frenzied
Language
unset
Current search:
microbiome
×
" seattle top stories "
×
" boston blog main "
×
" wisconsin blog main "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More